Monday, Evolus, Inc. (EOLS) announced the pricing of the underwritten offering of 3,554,000 shares of its common stock at $14.07 per share, matching the closing price on Friday, March 8, 2024.
The company expects gross proceeds of approximately $50 million, excluding underwriting discounts, commissions, and other offering expenses.
Moreover, the underwriters have the option to purchase up to 533,100 additional shares at the offering price minus underwriting discounts and commissions within 30 days.
The company plans to use the net proceeds to support Jeuveau's growth, fund the launch of Evolysse, explore potential business development opportunities, and for general corporate purposes.
The offering is projected to close around March 13, 2024, pending customary closing conditions, with Leerink Partners and Stifel serving as joint book-running managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.